US 12304908
Azabenzimidazoles and their use as AMPA receptor modulators
granted A61PA61P25/00
Quick answer
US patent 12304908 (Azabenzimidazoles and their use as AMPA receptor modulators) held by Rapport Therapeutics, Inc. expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rapport Therapeutics, Inc.
- Grant date
- Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P25/00